EDGAR Filing Documents for 0001192482-15-000362

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001192482-15-000362

Filing Date

2015-08-06

Accepted

2015-08-06 14:30:20

Documents

Period of Report

2015-08-04

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	edgar.html	4
1	PRIMARY DOCUMENT	edgar.xml	4	3791
2	POA	poarask.htm	EX-24	3067
	Complete submission text file	0001192482-15-000362.txt		8365

Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333

Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505

Zynerba Pharmaceuticals, Inc. (Issuer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZYNERBA PHARMACEUTICALS, INC. 80 W. LANCASTER AVENUE DEVON PA 19333

Business Address

Type: 4 | Act: 34 | File No.: 001-37526 | Film No.: 151032471